BioScience Health Innovations I

What they do

The company was incorporated in Nevada on July 8, 2019 as Nowtransit, Inc. and changed its name to BioScience Health Innovations Inc. on February 21, 2025. Its 10-K describes forward-looking statements about an acquisition opportunity, consistent with a company that had no operations and was seeking to acquire an operating business. The latest 10-Q balance sheet shows cash of $712,378, accounts receivable of $396,899, income tax receivable of $34,992, operating digital assets of $4,500 and inventory at June 30, 2026, but the excerpts do not identify the specific products or services behind the reported revenue.

Revenue drivers

• Unidentified operating business — The 10-K Item 1 does not name any product or service line; the only description of operations is the search for and acquisition of an operating business. Reported revenue of $5.7M in 2025 and $1.0M in the June 2026 quarter therefore comes from a business the filing excerpts do not identify.
• Inventory-bearing activity — The June 30, 2026 balance sheet shows an inventory line item (value not shown in the excerpt), indicating the company sells physical goods, but the item is unspecified in the source material.
• Receivables-based sales — Accounts receivable, net was $396,899 at June 30, 2026 versus $399,257 at December 31, 2025, showing revenue is billed to customers on credit, though no customer or segment is named.

Recent performance

Quarterly revenue was $1.6M in the quarter ended December 31, 2025, fell to $750,946 in the quarter ended March 31, 2026, and recovered to $1.0M in the quarter ended June 30, 2026. Full-year revenue grew from $1.8M in 2024 to $5.7M in 2025, with net income of $87,000 and $642,090 in those years respectively. Operating cash flow turned positive at $23,188 in 2024 and $172,178 in 2025 after negative $307,842 in 2023. At June 30, 2026, total assets were $2.1M, total liabilities $301,209, and shareholder equity $1.8M. Diluted EPS was $0.01 in 2024 and $0.06 in 2025.

Strategy

The 10-K states the company's stated focus is locating and acquiring an operating business, developing a viable business plan, and locating capital to meet its business needs. The company notes that because it has limited capital, it may need to raise additional capital by issuing debt or equity securities, which could dilute current investors or subordinate their rights. The filings also warn that any financing may be impaired by the capital markets, its limited operating history, the national and global economies, and the market for microcap securities. On April 2, 2026 the company reported a director or officer change in an 8-K, and on October 16, 2025 it reported amended charter or bylaws following a shareholder vote.

Risks

• Dilutive financing need — The company states that because it has limited capital it may need to issue debt or equity securities on terms that dilute or subordinate current investors.
• Financing availability — The 10-K says its ability to obtain financing may be impaired by its limited operating history and lack of operations, market conditions, and the market for microcap securities.
• Operating continuity — The risk factors state that if capital raised plus any revenue is insufficient, the company may have to cease operations, divest assets at unattractive prices, or take financing on unattractive terms.
• Unidentified revenue base — The provided 10-K Item 1 does not name the products, services, or customers behind the $5.7M of 2025 revenue, leaving the source of reported results unexplained in the excerpts.

Outlook

Management's stated direction is to locate and acquire an operating business and to build a viable business plan, and it describes its current acquisition opportunity in forward-looking statements. The filings also state that it may need additional capital and that its ability to raise it could be impaired by its limited operating history, market conditions and the microcap market. The excerpts do not provide specific revenue or earnings guidance for fiscal 2026. The 10-Q notes that results for the six months ended June 30, 2026 are not necessarily indicative of results for the full year.